Manipal Health Enterprises IPO
Healthcare • ₹9275cr
High risk because:
- Low institutional interest (QIB 0.1x subscription)
- 5 material risk factors disclosed in DRHP
- Heavy dependence on government or PSU customers
IPOFins risk score from DRHP risk factors, subscription demand & issue structure
Price Band
₹29-31
Lot Size
25 shares
Issue Size
₹9275cr
Open
29 Jul 2026
Close
31 Jul 2026
Subscription
0.15×
GMP +₹7 → est. ₹38
IPO Schedule
| Issue Open Date | 29 Jul 2026 |
| Issue Close Date | 31 Jul 2026 |
| Allotment Date | 03 Aug 2026 |
| Listing Date | 05 Aug 2026 |
About Manipal Health Enterprises
Manipal Health Enterprises Limited is a healthcare service provider engaged in running and managing hospitals, clinics and diagnostic centres, primarily in India. It operates a network of multi-speciality hospitals offering clinical services across several specialities, with a focus on tertiary and quaternary care such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and renal sciences. The company serves patients through inpatient and outpatient services, generating revenue from healthcare services paid by patients directly, insurance and third-party administrators, government schemes and corporate arrangements. Its network includes multiple hospitals supported by a large pool of doctors, and it caters to a significant volume of patients across its facilities. The company operates as a single business segment focused on medical and healthcare services, combining hospital infrastructure, clinical expertise and diagnostic capabilities to deliver care.   Discuss on Trading Q&A
Company Details
Founders / Promoters
Mr Dilip Jose
Founded
2010
Registrar
KARVY
Documents
DRHP / RHP Document (PDF)
View official prospectus →
Subscription Status
0.15×
Total Subscription
Grey Market Premium (GMP)
Issue Price
₹31
GMP
+₹7
Est. Listing
₹38
Est. Gain
+22.6%
GMP is unofficial grey market data — not regulated by SEBI. Use only as a sentiment indicator alongside subscription data. View all IPO GMP →
Investment Analysis
Manipal Health Enterprises — IPOFins Verdict
QuantitativeDriven by QIB demand at 0.1x and elevated disclosed risk (8/10). The signals look weak — weigh the risks carefully. This is a quantitative flag, not a recommendation.
- A large network of multi-speciality hospitals supported by a wide base of doctors.
- Focus on high-end specialities like cardiac, oncology and neurosciences, driving revenue.
- Strong presence across key regions with ongoing expansion plans.
- Significant share of revenue from insurance and institutional payors.
- Established track record of growth in patient volumes and operations.
Score breakdown — what drove this verdict
High risk from DRHP → score -1.2
Institutional subscription → score −1.5
Base score: 5.0 · Final score = base + all factor adjustments, capped 1–10. Full methodology →
IPOFins Score is a quantitative signal from subscription demand, disclosed risk, and listing data — not investment advice. Not SEBI-registered.
Want to apply for this IPO?
Open a free Demat account and apply in minutes
FAQ
What is the price band of Manipal Health Enterprises IPO?
The price band is ₹29-31 per share with a lot size of 25 shares. Minimum investment: ₹775.
What does Manipal Health Enterprises do?
Manipal Health Enterprises Limited is a healthcare service provider engaged in running and managing hospitals, clinics and diagnostic centres, primarily in India. It operates a network of multi-speciality hospitals offering clinical services across several specialities, with a focus on tertiary and quaternary care such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and renal sciences. The company serves patients through inpatient and outpatient services, generating revenue from healthcare services paid by patients directly, insurance and third-party administrators, government schemes and corporate arrangements. Its network includes multiple hospitals supported by a large pool of doctors, and it caters to a significant volume of patients across its facilities. The company operates as a single business segment focused on medical and healthcare services, combining hospital infrastructure, clinical expertise and diagnostic capabilities to deliver care.   Discuss on Trading Q&A
Should I apply for Manipal Health Enterprises IPO?
Manipal Health Enterprises is drawing muted interest at 0.1x overall subscription (QIB 0.1x, retail 0.3x). IPOFins Score 2/10: Driven by QIB demand at 0.1x and elevated disclosed risk (8/10). The signals look weak — weigh the risks carefully. This is a quantitative flag, not a recommendation.
Who founded Manipal Health Enterprises?
Manipal Health Enterprises was founded by Mr Dilip Jose in 2010.